Literature DB >> 11431162

Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line.

M T Ling1, K W Chan, C K Choo.   

Abstract

Androgen signaling is crucial for the growth and development, as well as for tumorigenesis of the prostate. However, many of the prostate epithelial cell lines developed previously, either normal or tumorigenic, do not express androgen receptor (AR) or respond to androgen. In order to advance our understanding on how androgen signaling regulates the growth and the differentiation status, and affects tumorigenicity of the epithelial cell, we performed experiments on HPr-1, a prostate cell line recently immortalized from normal human prostate epithelial cells. In the present study, AR was stably transfected into HPr-1 cells by replication-defective retrovirus. Treatment of HPr-1AR cells with androgen resulted in cell differentiation and growth retardation accompanied with up-regulation of cytokeratins K8 and K18, prostate specific antigen, p21 and p27, and down-regulation of c-myc, bcl-2 and telomerase activity. Our results suggest that androgen promotes the process of differentiation in a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line which may reflect the normal effects of androgen on prostate cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431162     DOI: 10.1677/joe.0.1700287

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  26 in total

1.  APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

Authors:  Maricel Maffini; Viktoria Denes; Carlos Sonnenschein; Ana Soto; Peter Geck
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-12       Impact factor: 4.292

Review 2.  The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis.

Authors:  Joanne N Davis; Mark L Day
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

3.  The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.

Authors:  Neha G Sabnis; Austin Miller; Mark A Titus; Wendy J Huss
Journal:  Mol Cancer Res       Date:  2016-11-17       Impact factor: 5.852

4.  Supervillin associates with androgen receptor and modulates its transcriptional activity.

Authors:  Huei-Ju Ting; Shuyuan Yeh; Kazuo Nishimura; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  Myc confers androgen-independent prostate cancer cell growth.

Authors:  David Bernard; Albin Pourtier-Manzanedo; Jesús Gil; David H Beach
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells.

Authors:  Hongbo Wang; Daqian Sun; Peng Ji; James Mohler; Liang Zhu
Journal:  J Cell Sci       Date:  2008-07-15       Impact factor: 5.285

7.  Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells.

Authors:  Congcong Chen; Jason A Dienhart; Eric C Bolton
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

8.  Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.

Authors:  Lizamma Antony; Freek van der Schoor; Susan L Dalrymple; John T Isaacs
Journal:  Prostate       Date:  2014-06-09       Impact factor: 4.104

9.  Cell- and gene-specific regulation of primary target genes by the androgen receptor.

Authors:  Eric C Bolton; Alex Y So; Christina Chaivorapol; Christopher M Haqq; Hao Li; Keith R Yamamoto
Journal:  Genes Dev       Date:  2007-08-15       Impact factor: 11.361

10.  Finasteride accelerates prostate wound healing after thulium laser resection through DHT and AR signalling.

Authors:  Ruizhe Zhao; Xingjie Wang; Chenyi Jiang; Fei Shi; Yiping Zhu; Boyu Yang; Jian Zhuo; Yifeng Jing; Guangheng Luo; Shujie Xia; Bangmin Han
Journal:  Cell Prolif       Date:  2017-11-30       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.